Niagen Bioscience(DE:OCD1)
€1.88-0.01 (-0.53%)
DE:OCD1
Niagen Bioscience earnings date
€1.88
At close:-0.01 (-0.53%)
Niagen Bioscience (OCD1) Q4 2021 Earnings Report
2 Followers
DE:OCD1 Q4 2021 EPS Results
- Actual EPS
- -EUR 0.07
- Consensus EPS
- -EUR 0.09
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- -EUR 0.09
DE:OCD1 Q4 2021 Revenue Results
- Actual Revenue
- EUR 15.90M
- Expected Revenue
- EUR 16.63M
- Beat/Miss
- Missed by -EUR 725.23K
- YoY Revenue Growth
- +14.98%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 03/09/2022
- Time
- After Close
- Conference Call
- Wednesday, March 9, 2022
DE:OCD1 Upcoming Earnings
Niagen Bioscience's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:OCD1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | -0.02- | 0.04 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -0.01-0.01 | 0.04 | -120.00% (-0.05) | |
| Aug 04, 2026 | 2026 (Q2) | 0.010.01 | 0.04 | -75.00% (-0.03) | |
| May 06, 2026 | 2026 (Q1) | 0.060.06 | 0.05 | 16.67% (+0.01) | |
| Mar 04, 2026 | 2025 (Q4) | 0.020.04 | 0.08 | -44.44% (-0.04) | |
| Nov 04, 2025 | 2025 (Q3) | 0.020.04 | 0.03 | 72.41% (+0.02) | |
| Aug 06, 2025 | 2025 (Q2) | 0.010.04 | 0 | ― | |
| May 07, 2025 | 2025 (Q1) | 0.020.05 | -0.01 | 700.00% (+0.06) | |
| Mar 04, 2025 | 2024 (Q4) | 0.020.08 | 0 | ― | |
| Oct 31, 2024 | 2024 (Q3) | 0.010.03 | 0 | 480.00% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
